Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
deals
4
×
hepatitis b
4
×
life sciences
national blog main
national top stories
boehringer ingelheim
san francisco blog main
alexion pharmaceuticals
alnylam pharmaceuticals
boston
clinical trials
eli lilly
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
rna interference
san francisco top stories
startups
wisconsin blog main
wisconsin top stories
abbvie
allergan aesthetics
alnylam pharmaceutials
alzheimer's disease
amgen
arrowhead pharmaceuticals
astrazeneca
athira pharma
attralus
beijing
biontech
boulder/denver blog main
boulder/denver top stories
brii bio
brii biosciences
cancer
What
drug
medicines
dicerna
disease
hepatitis
pharma
pipeline
abandoning
acquisitions
adds
ago
alliance
areas
baggage
biggest
bio
biosciences
bio’s
brii
build
buy
caught
causing
ceo
companies
company’s
cuts
daniel
deal
debut
development
dyne’s
earlier
eye
free
gene
gets
gilead
infectious
intended
Language
unset
Current search:
deals
×
" hepatitis b "
×
biotech
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
